US FDA declines to approve Capricor's muscle disorder therapy - TradingView

Reuters | July 11, 2025, 6:34 a.m. | Original
US FDA declines to approve Capricor's muscle disorder therapy TradingView
India's Vedanta Ltd rises, JPMorgan sees no financial stress at firm - TradingView Russian court approves seizure of owner's stake in gold producer Uzhuralzoloto, UGC lawyer says - TradingView